Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
No dosing or regimen recommendations are provided or implied for human or veterinary use
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
(Uses, Benefits, Dosages and Injection Frequency) Understanding MIC B12 shots
HCPCS Code T1017 is the billing code for targeted case management services, billed in 15-minute increments
US$ 22.10
US$ 21.81
US$ 24.08
US$ 27.99
US$ 24.39
US$ 29.03
